Tyra Biosciences to Present at the Cantor Global Healthcare Conference
Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on FGFR-targeted precision medicines, announced its participation in the Cantor Global Healthcare Conference 2026. The event will feature a virtual fireside chat and one-on-one investor meetings scheduled for Wednesday, September 9, 2026 at 1:00 PM ET. A live webcast of the presentation will be available on Tyra's website under the 'For Investors' section with replay access afterward. Tyra is leveraging its SNÅP platform to develop next-generation precision medicines across oncology and genetically defined conditions, including dabogratinib for FGFR3-related diseases and TYRA-430/TYRA-200 in advanced cancer trials.
Tickers: $TYRA
Topics: biotechnology investor relations